- Report
- January 2026
- 474 Pages
Global
From €5161EUR$5,850USD£4,502GBP
- Report
- January 2026
- 285 Pages
Global
From €5161EUR$5,850USD£4,502GBP
- Report
- January 2026
- 279 Pages
Global
From €5161EUR$5,850USD£4,502GBP
- Report
- January 2026
- 282 Pages
Global
From €5161EUR$5,850USD£4,502GBP
- Report
- January 2026
- 279 Pages
Global
From €5161EUR$5,850USD£4,502GBP
- Report
- January 2026
- 278 Pages
Global
From €5161EUR$5,850USD£4,502GBP
- Report
- January 2026
- 288 Pages
Global
From €5161EUR$5,850USD£4,502GBP
- Report
- January 2026
- 220 Pages
Global
From €5161EUR$5,850USD£4,502GBP
- Report
- January 2026
- 171 Pages
Global
From €5161EUR$5,850USD£4,502GBP
- Report
- January 2026
- 490 Pages
Global
From €5161EUR$5,850USD£4,502GBP
- Report
- January 2026
- 377 Pages
Global
From €5161EUR$5,850USD£4,502GBP
- Report
- January 2026
- 282 Pages
Global
From €5161EUR$5,850USD£4,502GBP
- Report
- January 2026
- 371 Pages
Global
From €5161EUR$5,850USD£4,502GBP
- Report
- January 2026
- 475 Pages
Global
From €5161EUR$5,850USD£4,502GBP
- Report
- January 2026
- 373 Pages
Global
From €5161EUR$5,850USD£4,502GBP
- Report
- January 2026
- 563 Pages
Global
From €5161EUR$5,850USD£4,502GBP
- Report
- January 2026
- 276 Pages
Global
From €5161EUR$5,850USD£4,502GBP
- Report
- January 2026
- 375 Pages
Global
From €5161EUR$5,850USD£4,502GBP
- Report
- January 2026
- 576 Pages
Global
From €5161EUR$5,850USD£4,502GBP
- Report
- January 2026
- 376 Pages
Global
From €5161EUR$5,850USD£4,502GBP

The Vaccine Adjuvant market is a subset of the Vaccines market, which is composed of products that are used to enhance the effectiveness of vaccines. Vaccine adjuvants are substances that are added to vaccines to increase the body's immune response to the vaccine. Adjuvants can be either natural or synthetic, and can be used to increase the potency of a vaccine, reduce the amount of antigen needed, or to extend the duration of the vaccine's effectiveness. Vaccine adjuvants are used in a variety of vaccines, including those for influenza, hepatitis, and human papillomavirus.
Some companies in the Vaccine Adjuvant market include GlaxoSmithKline, Merck, Sanofi, and Novartis. Show Less Read more